Research

Ebola
Biotech

US taps small biotech for experimental Ebola treatment

Mapp Biopharmaceutical has shipped doses of an experimental Ebola antibody treatment for potential use in people at high risk.
Annaliesa Anderson

Pfizer ‘comfortable’ joining fights with hantavirus, Ebola: exec

May 20, 2026 5:05am
Artificial intelligence

Incyte inks deal with Edison to train AI through drug discovery

May 19, 2026 10:30am
NVS

Novartis trims ‘select number’ of biomedical research roles

May 15, 2026 10:58am
Lab mouse running through a maze

Protective gene sent to the liver cleared brain amyloid in mice

May 8, 2026 1:15pm
Antibodies binding to measles

New antibodies stop measles from stabbing cells, study finds

May 7, 2026 11:00am